Inventor · disambiguated record
Michael Weichel
Also filed as: WEICHEL MICHAEL
11 granted patents·5 pending applications·64 citations·filing 2012–2023
89Inventor score
Files withAFFIMED GMBH6AMPHIVENA THERAPEUTICS INC4GANYMED PHARMACEUTICALS AG2GANYMED PHARMACEUTICALS GMBH2LITTLE MELVYN1
Top patents by PatentIndex Score
16 records- 0193US11859008B2Antibodies for treatment of cancer expressing claudin 6GANYMED PHARMACEUTICALS GMBH·Filed 2020·Granted Jan 2, 2024·2 cites·12 claims
- 0292US9321842B2Antibodies for treatment of cancerSAHIN UGUR·Filed 2012·Granted Apr 26, 2016·14 cites·30 claims
- 0392US9212225B1Bispecific CD33 and CD3 binding proteinsAMPHIVENA THERAPEUTICS INC·Filed 2015·Granted Dec 15, 2015·17 cites·14 claims
- 0490US10233253B2Antibodies for treatment of cancer expressing claudin 6GANYMED PHARMACEUTICALS AG·Filed 2016·Granted Mar 19, 2019·7 cites·16 claims
- 0590US9803029B2Bispecific CD33 and CD3 binding proteinsAMPHIVENA THERAPEUTICS INC·Filed 2015·Granted Oct 31, 2017·11 cites·18 claims
- 0688US10626190B2Bispecific CD33 and CD3 binding proteinsAMPHIVENA THERAPEUTICS INC·Filed 2017·Granted Apr 21, 2020·3 cites·12 claims
- 0785US10066015B2CD3 binding domainsAFFIMED GMBH·Filed 2015·Granted Sep 4, 2018·10 cites·11 claims
- 0884US2024101703A1Antibodies for treatment of cancer expressing claudin 6GANYMED PHARMACEUTICALS GMBH·Filed 2023·Application pending·0 cites
- 0968US10919974B2Antibodies for treatment of cancer expressing claudin 6GANYMED PHARMACEUTICALS AG·Filed 2018·Granted Feb 16, 2021·0 cites·12 claims
- 1065US12264198B2Tandem diabody for CD16A-directed NK-cell engagementAFFIMED GMBH·Filed 2021·Granted Apr 1, 2025·0 cites·11 claims
- 1165US2021024654A1Bispecific CD33 and CD3 Binding ProteinsAMPHIVENA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1260US11180558B2Tandem diabody for CD16A-directed NK-cell engagementAFFIMED GMBH·Filed 2019·Granted Nov 23, 2021·0 cites·11 claims
- 1356US2022048994A1Trifunctional antigen-binding moleculeLITTLE MELVYN·Filed 2021·Application pending·0 cites
- 1456US2022340674A1Method for the production of bispecific fcyriii x cd30 antibody constructAFFIMED GMBH·Filed 2022·Application pending·0 cites
- 1544US11572415B2Multivalent FV antibodiesAFFIMED GMBH·Filed 2018·Granted Feb 7, 2023·0 cites·25 claims
- 1642US2017037128A1Trifunctional antigen-binding moleculeAFFIMED GMBH·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Michael Weichel files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →